These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 8024993)

  • 1. Clinical feminisation and sex hormone concentrations in Nigerian men with cirrhosis with and without hepatocellular carcinoma.
    Olubuyide IO; Ola OS
    Br J Clin Pract; 1994; 48(2):70-2. PubMed ID: 8024993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low serum testosterone: a special feature of hepatocellular carcinoma.
    Lampropoulou-Karatzas C; Goritsas P; Makri MG
    Eur J Med; 1993 Jan; 2(1):23-7. PubMed ID: 8258001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum testosterone:estradiol ratio and the development of hepatocellular carcinoma among male cirrhotic patients.
    Tanaka K; Sakai H; Hashizume M; Hirohata T
    Cancer Res; 2000 Sep; 60(18):5106-10. PubMed ID: 11016636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatocellular carcinoma in alcoholic cirrhosis: is sex hormone imbalance a pathogenetic factor?
    Farinati F; De Maria N; Marafin C; Fagiuoli S; Della Libera G; Naccarato R
    Eur J Gastroenterol Hepatol; 1995 Feb; 7(2):145-50. PubMed ID: 7712307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Gonadal dysfunctions in liver cirrhosis].
    Morimoto I
    Nihon Rinsho; 1994 Jan; 52(1):132-7. PubMed ID: 8114282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oestradiol and testosterone blood levels in patients with viral cirrhosis and hepatocellular carcinoma.
    Pignata S; Daniele B; Galati MG; Esposito G; Vallone P; Fiore F; Ricchi P; Pergola M
    Eur J Gastroenterol Hepatol; 1997 Mar; 9(3):283-6. PubMed ID: 9096431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Androgen-oestrogen imbalance in men with chronic alcoholism and fatty liver.
    Myking O; Aakvaag A; Digranes O
    Alcohol Alcohol; 1987; 22(1):7-15. PubMed ID: 3593486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transforming growth factor beta1 and soluble Fas serum levels in hepatocellular carcinoma.
    Sacco R; Leuci D; Tortorella C; Fiore G; Marinosci F; Schiraldi O; Antonaci S
    Cytokine; 2000 Jun; 12(6):811-4. PubMed ID: 10843770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiopoietin-2 serum levels are elevated in patients with liver cirrhosis and hepatocellular carcinoma.
    Scholz A; Rehm VA; Rieke S; Derkow K; Schulz P; Neumann K; Koch I; Pascu M; Wiedenmann B; Berg T; Schott E
    Am J Gastroenterol; 2007 Nov; 102(11):2471-81. PubMed ID: 17581268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. May plasma cholesterol level be considered a neoplastic marker in liver disease from cirrhosis to hepatocellular carcinoma?
    Venturini I; Amedei R; Modonesi G; Cosenza R; Miglioli L; Cioni G; Zeneroli ML
    Ital J Gastroenterol Hepatol; 1999; 31(1):61-5. PubMed ID: 10091105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum erythropoietin measurements by a one-step sandwich enzyme linked immunosorbent assay in patients with hepatocellular carcinoma and liver cirrhosis.
    Sawabe Y; Iida S; Tabata Y; Yonemitsu H
    Jpn J Clin Oncol; 1993 Oct; 23(5):273-7. PubMed ID: 7693989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrogens, testosterone and sex hormone binding globulin in relation to liver cancer in men.
    Kuper H; Mantzoros C; Lagiou P; Tzonou A; Tamimi R; Mucci L; Benetou V; Spanos E; Stuver SO; Trichopoulos D
    Oncology; 2001; 60(4):355-60. PubMed ID: 11408804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated plasma levels of matrix metalloproteinase-9 (92-kd type IV collagenase/gelatinase B) in hepatocellular carcinoma.
    Hayasaka A; Suzuki N; Fujimoto N; Iwama S; Fukuyama E; Kanda Y; Saisho H
    Hepatology; 1996 Nov; 24(5):1058-62. PubMed ID: 8903375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum selenium concentration in patients with liver cirrhosis and hepatocellular carcinoma.
    Buljevac M; Romić Z; Vucelić B; Banić M; Krznarić Z; Plesko S
    Acta Med Croatica; 1996; 50(1):11-4. PubMed ID: 8776109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased IGF-I : IGFBP-3 ratio in patients with hepatocellular carcinoma.
    Mattera D; Capuano G; Colao A; Pivonello R; Manguso F; Puzziello A; D'Agostino L
    Clin Endocrinol (Oxf); 2003 Dec; 59(6):699-706. PubMed ID: 14974910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does the concentration of alpha 1-proteinase inhibitor reflect the transformation of liver cirrhosis to liver carcinoma?
    Dabrowska M; Mantur M; Panasiuk A; Prokopowicz J
    Neoplasma; 1997; 44(5):305-7. PubMed ID: 9473790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sex steroids and bone turnover markers in men with symptomatic vertebral fractures.
    Tuck SP; Scane AC; Fraser WD; Diver MJ; Eastell R; Francis RM
    Bone; 2008 Dec; 43(6):999-1005. PubMed ID: 18817902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The significance of serum levels of adiponectin, leptin, and hyaluronic acid in hepatocellular carcinoma of cirrhotic and noncirrhotic patients.
    Sadik NA; Ahmed A; Ahmed S
    Hum Exp Toxicol; 2012 Apr; 31(4):311-21. PubMed ID: 22249387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytokine evaluation in liver cirrhosis and hepatocellular carcinoma.
    Cheng KS; Tang HL; Chou FT; Chou JW; Hsu CH; Yu CJ; Kao ST; Li TC
    Hepatogastroenterology; 2009; 56(93):1105-10. PubMed ID: 19760951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High plasma concentrations of nitrite/nitrate in patients with hepatocellular carcinoma.
    Moriyama A; Masumoto A; Nanri H; Tabaru A; Unoki H; Imoto I; Ikeda M; Otsuki M
    Am J Gastroenterol; 1997 Sep; 92(9):1520-3. PubMed ID: 9317076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.